186 related articles for article (PubMed ID: 28981818)
1. A prospective study of immune and inflammation markers and risk of lung cancer among female never smokers in Shanghai.
Shiels MS; Shu XO; Chaturvedi AK; Gao YT; Xiang YB; Cai Q; Hu W; Shelton G; Ji BT; Pinto LA; Kemp TJ; Rothman N; Zheng W; Hildesheim A; Lan Q
Carcinogenesis; 2017 Oct; 38(10):1004-1010. PubMed ID: 28981818
[TBL] [Abstract][Full Text] [Related]
2. Circulating inflammation markers and prospective risk for lung cancer.
Shiels MS; Pfeiffer RM; Hildesheim A; Engels EA; Kemp TJ; Park JH; Katki HA; Koshiol J; Shelton G; Caporaso NE; Pinto LA; Chaturvedi AK
J Natl Cancer Inst; 2013 Dec; 105(24):1871-80. PubMed ID: 24249745
[TBL] [Abstract][Full Text] [Related]
3. Cigarette smoking and variations in systemic immune and inflammation markers.
Shiels MS; Katki HA; Freedman ND; Purdue MP; Wentzensen N; Trabert B; Kitahara CM; Furr M; Li Y; Kemp TJ; Goedert JJ; Chang CM; Engels EA; Caporaso NE; Pinto LA; Hildesheim A; Chaturvedi AK
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25274579
[TBL] [Abstract][Full Text] [Related]
4. Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.
Pine SR; Mechanic LE; Enewold L; Chaturvedi AK; Katki HA; Zheng YL; Bowman ED; Engels EA; Caporaso NE; Harris CC
J Natl Cancer Inst; 2011 Jul; 103(14):1112-22. PubMed ID: 21685357
[TBL] [Abstract][Full Text] [Related]
5. Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.
Shiels MS; Katki HA; Hildesheim A; Pfeiffer RM; Engels EA; Williams M; Kemp TJ; Caporaso NE; Pinto LA; Chaturvedi AK
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26220734
[TBL] [Abstract][Full Text] [Related]
6. Endogenous sex hormones, aromatase activity and lung cancer risk in postmenopausal never-smoking women.
Zhao Y; Gao YT; Zhang X; Rockwood AL; Kushnir MM; Cai Q; Wu J; Shi J; Lan Q; Rothman N; Shyr Y; Shu XO; Zheng W; Yang G
Int J Cancer; 2022 Sep; 151(5):699-707. PubMed ID: 35338778
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory Cytokines and Lung Cancer Risk in 3 Prospective Studies.
Brenner DR; Fanidi A; Grankvist K; Muller DC; Brennan P; Manjer J; Byrnes G; Hodge A; Severi G; Giles GG; Johansson M; Johansson M
Am J Epidemiol; 2017 Jan; 185(2):86-95. PubMed ID: 27998891
[TBL] [Abstract][Full Text] [Related]
8. Circulating high sensitivity C reactive protein concentrations and risk of lung cancer: nested case-control study within Lung Cancer Cohort Consortium.
Muller DC; Larose TL; Hodge A; Guida F; Langhammer A; Grankvist K; Meyer K; Cai Q; Arslan AA; Zeleniuch-Jacquotte A; Albanes D; Giles GG; Sesso HD; Lee IM; Gaziano JM; Yuan JM; Hoffman Bolton J; Buring JE; Visvanathan K; Le Marchand L; Purdue MP; Caporaso NE; Midttun Ø; Ueland PM; Prentice RL; Weinstein SJ; Stevens VL; Zheng W; Blot WJ; Shu XO; Zhang X; Xiang YB; Koh WP; Hveem K; Thomson CA; Pettinger M; Engström G; Brunnström H; Milne RL; Stampfer MJ; Han J; Johansson M; Brennan P; Severi G; Johansson M
BMJ; 2019 Jan; 364():k4981. PubMed ID: 30606716
[TBL] [Abstract][Full Text] [Related]
9. Occupational exposure to diesel engine exhaust and alterations in immune/inflammatory markers: a cross-sectional molecular epidemiology study in China.
Bassig BA; Dai Y; Vermeulen R; Ren D; Hu W; Duan H; Niu Y; Xu J; Shiels MS; Kemp TJ; Pinto LA; Fu W; Meliefste K; Zhou B; Yang J; Ye M; Jia X; Meng T; Wong JYY; Bin P; Hosgood HD; Hildesheim A; Silverman DT; Rothman N; Zheng Y; Lan Q
Carcinogenesis; 2017 Oct; 38(11):1104-1111. PubMed ID: 28968774
[TBL] [Abstract][Full Text] [Related]
10. Association of Untargeted Urinary Metabolomics and Lung Cancer Risk Among Never-Smoking Women in China.
Seow WJ; Shu XO; Nicholson JK; Holmes E; Walker DI; Hu W; Cai Q; Gao YT; Xiang YB; Moore SC; Bassig BA; Wong JYY; Zhang J; Ji BT; Boulangé CL; Kaluarachchi M; Wijeyesekera A; Zheng W; Elliott P; Rothman N; Lan Q
JAMA Netw Open; 2019 Sep; 2(9):e1911970. PubMed ID: 31539079
[TBL] [Abstract][Full Text] [Related]
11. Circulating Biomarkers of Inflammation and Ovarian Cancer Risk in the Nurses' Health Studies.
Peres LC; Townsend MK; Birmann BM; Conejo-Garcia JR; Kim Y; Kubzansky LD; Magpantay LI; Martinez-Maza O; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):710-718. PubMed ID: 33563649
[TBL] [Abstract][Full Text] [Related]
12. Associations between self-reported diabetes and 78 circulating markers of inflammation, immunity, and metabolism among adults in the United States.
Van Dyke AL; Lang Kuhs KA; Shiels MS; Koshiol J; Trabert B; Loftfield E; Purdue MP; Wentzensen N; Pfeiffer RM; Katki HA; Hildesheim A; Kemp TJ; Pinto LA; Chaturvedi AK; Safaeian M
PLoS One; 2017; 12(7):e0182359. PubMed ID: 28753646
[TBL] [Abstract][Full Text] [Related]
13. Circulating inflammation markers and risk of epithelial ovarian cancer.
Clendenen TV; Lundin E; Zeleniuch-Jacquotte A; Koenig KL; Berrino F; Lukanova A; Lokshin AE; Idahl A; Ohlson N; Hallmans G; Krogh V; Sieri S; Muti P; Marrangoni A; Nolen BM; Liu M; Shore RE; Arslan AA
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):799-810. PubMed ID: 21467242
[TBL] [Abstract][Full Text] [Related]
14. Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture.
Matsumiya T; Imaizumi T; Fujimoto K; Cui X; Shibata T; Tamo W; Kumagai M; Tanji K; Yoshida H; Kimura H; Satoh K
Exp Cell Res; 2001 Sep; 269(1):35-41. PubMed ID: 11525637
[TBL] [Abstract][Full Text] [Related]
15. Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.
Trabert B; Eldridge RC; Pfeiffer RM; Shiels MS; Kemp TJ; Guillemette C; Hartge P; Sherman ME; Brinton LA; Black A; Chaturvedi AK; Hildesheim A; Berndt SI; Safaeian M; Pinto L; Wentzensen N
Int J Cancer; 2017 Feb; 140(3):600-610. PubMed ID: 27770434
[TBL] [Abstract][Full Text] [Related]
16. Variation in oral microbiome is associated with future risk of lung cancer among never-smokers.
Hosgood HD; Cai Q; Hua X; Long J; Shi J; Wan Y; Yang Y; Abnet C; Bassig BA; Hu W; Ji BT; Klugman M; Xiang Y; Gao YT; Wong JY; Zheng W; Rothman N; Shu XO; Lan Q
Thorax; 2021 Mar; 76(3):256-263. PubMed ID: 33318237
[TBL] [Abstract][Full Text] [Related]
17. Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3).
Huang JY; Larose TL; Luu HN; Wang R; Fanidi A; Alcala K; Stevens VL; Weinstein SJ; Albanes D; Caporaso NE; Purdue MP; Ziegler RG; Freedman ND; Lan Q; Prentice RL; Pettinger M; Thomson CA; Cai Q; Wu J; Blot WJ; Shu XO; Zheng W; Arslan AA; Zeleniuch-Jacquotte A; Le Marchand L; Wilkens LR; Haiman CA; Zhang X; Stampfer MJ; Han J; Giles GG; Hodge AM; Severi G; Johansson M; Grankvist K; Langhammer A; Hveem K; Xiang YB; Li HL; Gao YT; Visvanathan K; Ueland PM; Midttun Ø; Ulvi A; Buring JE; Lee IM; Sesso HD; Gaziano JM; Manjer J; Relton C; Koh WP; Brennan P; Johansson M; Yuan JM
Int J Cancer; 2020 May; 146(9):2394-2405. PubMed ID: 31276202
[TBL] [Abstract][Full Text] [Related]
18. Relationship of the oxidative damage biomarker 8-epi-prostaglandin F2α to risk of lung cancer development in the Shanghai Cohort Study.
Yuan JM; Carmella SG; Wang R; Tan YT; Adams-Haduch J; Gao YT; Hecht SS
Carcinogenesis; 2018 Jul; 39(7):948-954. PubMed ID: 29726912
[TBL] [Abstract][Full Text] [Related]
19. Prediagnostic levels of serum beta-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China.
Yuan JM; Ross RK; Chu XD; Gao YT; Yu MC
Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):767-73. PubMed ID: 11440962
[TBL] [Abstract][Full Text] [Related]
20. Associations of Insulin and IGFBP-3 with Lung Cancer Susceptibility in Current Smokers.
Ho GYF; Zheng SL; Cushman M; Perez-Soler R; Kim M; Xue X; Wang T; Schlecht NF; Tinker L; Rohan TE; Wassertheil-Smoller S; Wallace R; Chen C; Xu J; Yu H
J Natl Cancer Inst; 2016 Jul; 108(7):. PubMed ID: 27071409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]